Cambridge Equities, LP
Insider CIK 1629222 · NK 10% owner · NH 10% owner · HLGN 10% owner · SRNE 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio, Inc. | C Conversion deriv | 2026-03-31 | 2026-04-02 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion | 2026-03-31 | 2026-04-02 | 4,606,596 | $5.43 | $25.01M | 251,018,873 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2026-02-22 | 2026-02-24 | 114,329 | — | $0 | 114,329 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2026-02-22 | 2026-02-24 | 114,329 | — | $0 | 29,816,081 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2026-02-22 | 2026-02-24 | 58,170 | $8.70 | $506.1K | 29,757,911 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2026-02-10 | 2026-02-12 | 274,122 | — | $0 | 548,246 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2026-02-10 | 2026-02-12 | 118,560 | $6.93 | $821.6K | 29,701,752 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2026-02-10 | 2026-02-12 | 274,122 | — | $0 | 29,820,312 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise deriv | 2025-02-22 | 2025-02-25 | 114,329 | — | $0 | 228,658 | SEC↗ |
| IBRX ImmunityBio, Inc. | F Tax w/h | 2025-02-22 | 2025-02-25 | 42,071 | $3.42 | $143.9K | 29,546,190 | SEC↗ |
| IBRX ImmunityBio, Inc. | M Exercise | 2025-02-22 | 2025-02-25 | 114,329 | — | $0 | 29,588,261 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2024-12-10 | 2024-12-12 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion deriv | 2024-12-10 | 2024-12-12 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2024-12-10 | 2024-12-12 | 0 | $505000000.00 | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion deriv | 2024-12-10 | 2024-12-12 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion | 2024-12-10 | 2024-12-12 | 13,475,172 | $2.28 | $30.72M | 246,412,277 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion | 2024-12-10 | 2024-12-12 | 103,710,088 | $1.94 | $201.20M | 232,937,105 | SEC↗ |
| HLGN Heliogen, Inc. | P Buy | 2024-02-15 | 2024-02-20 | 442,298 | $1.52 | $672.3K | 442,298 | SEC↗ |
| IBRX ImmunityBio, Inc. | P Buy deriv | 2023-09-11 | 2023-09-13 | 0 | $200000000.00 | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-09-11 | 2023-09-13 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-09-11 | 2023-09-13 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-09-11 | 2023-09-13 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-09-11 | 2023-09-13 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other deriv | 2023-09-11 | 2023-09-13 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other | 2023-09-11 | 2023-09-13 | 129,127,017 | $1.29 | $166.57M | 129,227,017 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other | 2023-09-11 | 2023-09-13 | 32,606,985 | $1.29 | $42.06M | 32,606,985 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other | 2023-09-11 | 2023-09-13 | 47,557,934 | $1.29 | $61.35M | 47,557,934 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion deriv | 2022-12-12 | 2022-12-14 | 0 | — | $0 | 0 | SEC↗ |
| IBRX ImmunityBio, Inc. | C Conversion | 2022-12-12 | 2022-12-14 | 9,986,920 | $5.67 | $56.63M | 9,986,920 | SEC↗ |
| NH NantHealth, Inc. | J Other deriv | 2021-04-13 | 2021-04-15 | 5,000,000 | $5000000.00 | $25000.00B | 5,000,000 | SEC↗ |
| NH NantHealth, Inc. | P Buy | 2021-04-13 | 2021-04-15 | 1,689,189 | $2.96 | $5.00M | 1,689,189 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other | 2021-03-09 | 2021-03-11 | 7,976,159 | — | $0 | 7,976,159 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other | 2021-03-09 | 2021-03-11 | 8,383,414 | — | $0 | 8,383,414 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other | 2021-03-09 | 2021-03-11 | 221,130,000 | — | $0 | 261,705,814 | SEC↗ |
| IBRX ImmunityBio, Inc. | J Other | 2021-03-09 | 2021-03-11 | 5,723,182 | — | $0 | 29,473,932 | SEC↗ |
| NK NantKwest, Inc. | P Buy | 2020-06-29 | 2020-06-29 | 3,710,000 | $12.12 | $44.97M | 23,750,750 | SEC↗ |
| NK NantKwest, Inc. | O Exercise OTM deriv | 2019-03-21 | 2019-03-21 | 17,589,250 | — | $0 | 0 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2019-03-21 | 2019-03-21 | 1,851,500 | — | $0 | 0 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2019-03-21 | 2019-03-21 | 1,851,500 | $2.20 | $4.07M | 20,040,750 | SEC↗ |
| NK NantKwest, Inc. | O Exercise OTM | 2019-03-21 | 2019-03-21 | 17,589,250 | $2.00 | $35.18M | 18,189,250 | SEC↗ |
| NK NantKwest, Inc. | M Exercise deriv | 2018-07-11 | 2018-07-13 | 9,257 | — | $0 | 0 | SEC↗ |
| NK NantKwest, Inc. | M Exercise | 2018-07-11 | 2018-07-13 | 9,257 | $1.62 | $15.0K | 40,565,814 | SEC↗ |
| NK NantKwest, Inc. | G Gift | 2016-12-30 | 2017-01-04 | 450,000 | — | $0 | 40,556,557 | SEC↗ |
| NH NantHealth, Inc. | P Buy deriv | 2016-12-21 | 2016-12-23 | 10,000,000 | $10000000.00 | $100000.00B | 0 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | J Other deriv | 2016-07-08 | 2016-07-11 | 500,000 | — | $0 | 1,224,138 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2016-07-07 | 2016-07-11 | 7,878,098 | — | $0 | 0 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2016-06-29 | 2016-07-01 | 3,400 | $5.82 | $19.8K | 7,157,924 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2016-06-23 | 2016-06-24 | 6,901 | $5.85 | $40.4K | 7,161,324 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2016-06-15 | 2016-06-17 | 19,836 | $5.87 | $116.4K | 7,168,225 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2016-06-14 | 2016-06-15 | 15,972 | $6.11 | $97.6K | 720,174 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2016-06-13 | 2016-06-15 | 37,792 | $6.15 | $232.4K | 736,146 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2016-03-07 | 2016-03-08 | 85,300 | $6.17 | $526.3K | 773,938 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | S Sale | 2016-03-04 | 2016-03-08 | 14,700 | $6.34 | $93.2K | 859,238 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award | 2015-12-09 | 2015-12-10 | 39,764 | $7.93 | $315.3K | 873,938 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award | 2015-12-08 | 2015-12-09 | 14,000 | $8.01 | $112.1K | 834,174 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award | 2015-12-07 | 2015-12-09 | 100,000 | $7.89 | $789.0K | 820,174 | SEC↗ |
| NK NantKwest, Inc. | P Buy deriv | 2015-10-14 | 2015-10-16 | 2,000,000 | — | $0 | 2,000,000 | SEC↗ |
| NK NantKwest, Inc. | P Buy | 2015-08-21 | 2015-08-25 | 450,000 | $23.00 | $10.35M | 41,016,557 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | G Gift | 2015-07-28 | 2016-07-11 | 720,174 | — | $0 | 7,878,098 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | G Gift | 2015-07-28 | 2016-07-11 | 720,174 | — | $0 | 0 | SEC↗ |
| NK NantKwest, Inc. | A Award deriv | 2015-07-27 | 2015-08-04 | 900,000 | — | $0 | 900,000 | SEC↗ |
| NK NantKwest, Inc. | A Award | 2015-07-27 | 2015-08-04 | 600,000 | — | $0 | 600,000 | SEC↗ |